{"id":"NCT00197236","sponsor":"GlaxoSmithKline","briefTitle":"Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months","officialTitle":"Immunogenicity and Safety of GSK Biologicals' Inactivated Hepatitis A Vaccine (Havrix™) Co-administered With GSK Biologicals' DTaP Vaccine (Infanrix™) and Aventis Pasteur's Haemophilus b Conjugate Vaccine (ActHIB) in Healthy Children 15 Months of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-11-11","primaryCompletion":"2007-12-03","completion":"2007-12-03","firstPosted":"2005-09-20","resultsPosted":"2009-07-24","lastUpdate":"2018-08-20"},"enrollment":468,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Hepatitis A"],"interventions":[{"type":"BIOLOGICAL","name":"Havrix™","otherNames":[]},{"type":"BIOLOGICAL","name":"Infanrix™","otherNames":[]},{"type":"BIOLOGICAL","name":"ActHIB™","otherNames":[]}],"arms":[{"label":"Havrix Group","type":"ACTIVE_COMPARATOR"},{"label":"Infanrix + ActHIB→Havrix Group","type":"EXPERIMENTAL"},{"label":"Havrix + Infanrix + ActHIB Group","type":"ACTIVE_COMPARATOR"}],"summary":"This is a study to evaluate the immune response and safety of GSK Biologicals 2-dose inactivated hepatitis A vaccine when administered with a diphtheria, tetanus and pertussis combination (DTaP) vaccine and a Haemophilus influenza type B (Hib) vaccine in children 15 months of age. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.","primaryOutcome":{"measure":"Number of Seropositive Subjects for Anti-hepatitis A Virus (HAV) Antibodies Following the Second Dose of Havrix","timeFrame":"31 days following the second dose of Havrix™","effectByArm":[{"arm":"Havrix Group","deltaMin":88,"sd":null},{"arm":"Havrix + Infanrix + ActHIB Group","deltaMin":84,"sd":null},{"arm":"Infanrix + ActHIB→Havrix Group","deltaMin":77,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":7,"exclusionCount":18},"locations":{"siteCount":22,"countries":["United States"]},"refs":{"pmids":["21494175"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":5},"commonTop":["Irritability","Pain at the injection site","Redness at the injection site","Drowsiness","Loss of appetite"]}}